L25- peptide delivery 2

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/11

encourage image

There's no tags or description

Looks like no tags are added yet.

12 Terms

1
New cards

what are proteins modifications

can be made to protein drugs to improve stability, efficacy, pharmacokinetics

may be engineered using recombinant DNA tech or by chemical modification of protein

eg fusion proteins, antibody drug conjugates, humanisation of MABs, modified insulins

2
New cards

describe protein modifications in insulin

regular insulin exists in hexameric form-after subcutaneous injection must dissociate for absorption

modifications to insulin may change quaternary structure eg:

long acting-promote hexamer formation, reduce solubility, promote binding to plasma proteins

fast acting-prevent formation of dimers and hexamers=increase solubility

3
New cards

what is PEGylation of therapeutic proteins

the process of attaching polyethylene glycol (PEG) polymer chains to a therapeutic protein, peptide, or antibody

4
New cards

hydrophilicity and flexibility of PEG

hydrophilicity-improved solubility, reduced protein binding, improved bioavailability, avoids phagocytosis

flexibility-shielding antigenic sites, lower toxicity, proteolytic resistance, reduced clearance, better thermal and mechanical stability

5
New cards

specificity of PEGylation of therapeutic protein

can negatively affect protein activity

site specific PEGylation can occur so functional parts of protein not blocked:

PEGylation of N-terminus without cross reacting with lysine residues at 8.5pH

6
New cards

describe PEGylated insulin analogue

long acting, once daily basal insulin

PEGylation:

-reduces diffusion rate

-reduces renal clearance

-better stability vs proteases

phase I trials found glucose normalisation and dose reduction

significant reduction in HbA1c

liver specific action

but some showed increased fat content in liver

7
New cards

describe spray drying as an alternative formulation

continuous process whereas lyophilisation is batch

gentler

forms powder-don't need milling or sieving

particle size can be adjusted=changes dissolution rate

can be done aseptically

may allow room temp storage

8
New cards

describe nanoparticles as emerging protein delivery techs

polymer and lipid based nanoparticles-can encapsulate proteins

interest in many routes inc oral

can be modified with shielding molecules and targeting ligands-may facilitate intracellular delivery

avoid phagocytosis-alters particle size

9
New cards

describe polymeric controlled drug delivery systems

used for controlled protein delivery over long time-protein released as polymer degrades

most widely used polymers=hydrophobic and only soluble in organic solvents-not good for biologicals

need to generate emulsions to get hydrophilic biological drug into hydrophobic polymer

10
New cards

problems with polymeric controlled drug delivery systems

interfaces with air, solvents, surfaces, temp, degradation products at release site

11
New cards

what is micro-scale delivery

device implanted during out patient visit

each reservoir has 40 micrograms of drug

12
New cards

what is cell based protein delivery

allogenic cells

long term delivery

high cell density